Company:
DBV TECHNOLOGIES is a biopharmaceutical company founded in 2002. For more than 15 years, the teams have been developing a new immunotherapy route using the epicutaneous route, based on an innovative technological platform called Viaskin® as well as an access to the immune system, EPIT® (Epicutaneous Immunotherapy).
Business issue: How to support the company’s growth with a scalable and evolving Cloud platform?
Solutions deployed: Dynamics 365 Finance & Operations